Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.581CHF
−15.03 MCHF
5.61 MCHF
28.58 M
About MEDIGENE AG
Sector
Industry
CEO
Selwyn Ho
Website
Headquarters
Martinsried
Employees (FY)
86
Founded
1996
ISIN
DE000A1X3W00
FIGI
BBG00HPS33M9
MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. It focuses on the development of personalized T-cell based immunotherapies. It operates through the Immunotherapies and Other products segments. The company was founded by Ernst Ludwig Winnacker and Horst Domdey in June 1994 and is headquartered in Martinsried, Germany.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MDG1 is 1.126 CHF — it has decreased by 19.61% in the past 24 hours. Watch MEDIGENE AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange MEDIGENE AG stocks are traded under the ticker MDG1.
MDG1 stock has fallen by 6.56% compared to the previous week, the month change is a 19.61% fall, over the last year MEDIGENE AG has showed a 67.53% decrease.
We've gathered analysts' opinions on MEDIGENE AG future price: according to them, MDG1 price has a max estimate of 2.93 CHF and a min estimate of 2.18 CHF. Watch MDG1 chart and read a more detailed MEDIGENE AG stock forecast: see what analysts think of MEDIGENE AG and suggest that you do with its stocks.
MDG1 reached its all-time high on Sep 20, 2021 with the price of 3.912 CHF, and its all-time low was 1.126 CHF and was reached on Jun 20, 2024. View more price dynamics on MDG1 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MDG1 stock is 24.39% volatile and has beta coefficient of −0.12. Track MEDIGENE AG stock price on the chart and check out the list of the most volatile stocks — is MEDIGENE AG there?
Today MEDIGENE AG has the market capitalization of 32.22 M, it has decreased by 6.68% over the last week.
Yes, you can track MEDIGENE AG financials in yearly and quarterly reports right on TradingView.
MEDIGENE AG is going to release the next earnings report on Aug 8, 2024. Keep track of upcoming events with our Earnings Calendar.
MDG1 earnings for the last half-year are −0.34 CHF per share, whereas the estimation was −0.45 CHF, resulting in a 23.60% surprise. The estimated earnings for the next half-year are −0.27 CHF per share. See more details about MEDIGENE AG earnings.
MEDIGENE AG revenue for the last half-year amounts to 3.08 M CHF, despite the estimated figure of 2.55 M CHF. In the next half-year revenue is expected to reach 4.00 M CHF.
MDG1 net income for the last half-year is −8.56 M CHF, while the previous report showed −6.81 M CHF of net income which accounts for −25.67% change. Track more MEDIGENE AG financial stats to get the full picture.
No, MDG1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 1, 2024, the company has 86.00 employees. See our rating of the largest employees — is MEDIGENE AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIGENE AG EBITDA is −13.96 M CHF, and current EBITDA margin is −249.04%. See more stats in MEDIGENE AG financial statements.
Like other stocks, MDG1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIGENE AG stock right from TradingView charts — choose your broker and connect to your account.